B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC on SelectScience
Watch the latest scientific webinars on SelectScience.
Stay updated with breaking news from Checkpoint Blockade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Watch the latest scientific webinars on SelectScience.
Harnessing the body’s innate immune system may help tackle tumors that have eluded cutting-edge immune therapies like CAR-T cells and checkpoint inhibitors
20.01.2022 - LUND, SWEDEN / ACCESSWIRE / January 20, 2022 / BioInvent International (STO:BINV)Preclinical proof-of-concept data published in the January 20, 2022 edition of the Journal for ImmunoTherapy of Cancer (JITC)BioInvent International AB ('BioInvent') ... Seite 1
E-Mail The National Cancer Institute (NCI) has granted a $2.5 million, five-year R37 MERIT Award to Dr. Bryan Burt, associate professor of surgery and chief of the Division of General Thoracic Surgery, for his research project titled, "Proteomic Determinants of Response to Checkpoint Blockade in Malignant Pleural Mesothelioma." "Malignant pleural mesothelioma (MPM) is a fatal cancer of the lining of the lungs that has defeated standard therapies for decades. In recent years, emerging clinical data has shown that treatment with a form of immunotherapy called immune checkpoint inhibitors (ICI...
SOUTHAMPTON scientists have made a major breakthrough that could help patients with mesothelioma survive for longer.